Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2020, Issue -, Pages 1-13
Publisher
Hindawi Limited
Online
2020-04-30
DOI
10.1155/2020/8680692
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Talimogene laherparepvec: First in class oncolytic virotherapy
- (2018) Robert M. Conry et al. Human Vaccines & Immunotherapeutics
- The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells
- (2018) Xinxin Li et al. OncoImmunology
- Fusogenic Viruses in Oncolytic Immunotherapy
- (2018) Teresa Krabbe et al. Cancers
- Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
- (2018) Jonathan G. Pol et al. OncoImmunology
- Engineered oncolytic viruses to treat melanoma: where are we now and what comes next?
- (2018) Luke D. Rothermel et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Dead Tumor Cells Expressing Infectious Salmon Anemia Virus Fusogenic Protein Favor Antigen Cross-Priming In Vitro
- (2017) Jonathan Morales et al. Frontiers in Immunology
- Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models
- (2017) Fabrice Le Boeuf et al. Molecular Therapy-Oncolytics
- The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
- (2016) Elizabeth. C. Carroll et al. IMMUNITY
- From mice to humans: developments in cancer immunoediting
- (2015) Michele W.L. Teng et al. JOURNAL OF CLINICAL INVESTIGATION
- Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency
- (2015) Olga V Matveeva et al. Molecular Therapy-Oncolytics
- Anti-tumor Effects of Gene Therapy with GALV Membrane Fusion Glycoprotein in Lung Adenocarcinoma
- (2014) Bing Zhu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Spectrum and Mechanisms of Inflammasome Activation by Chitosan
- (2014) C. L. Bueter et al. JOURNAL OF IMMUNOLOGY
- Low Molecular Weight Chitosan (LMWC)-based Polyplexes for pDNA Delivery: From Bench to Bedside
- (2014) Mireia Agirre et al. Polymers
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Chitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis
- (2011) Chelsea L. Bueter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Preparation, characterization and transfection efficacy of chitosan nanoparticles containing the intestinal trefoil factor gene
- (2011) Yong Sun et al. MOLECULAR BIOLOGY REPORTS
- Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer
- (2009) E-H Lin et al. CANCER GENE THERAPY
- Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytia
- (2008) Dennis Hoffmann et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now